FDA acts against unapproved colchicine

Feb 06, 2008

The U.S. Food and Drug Administration said it will take action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

Colchicine is a highly toxic drug that can easily be administered in excessive doses, especially when given intravenously, the FDA said, noting there's only a narrow margin between an effective dose of the drug and a toxic, perhaps even fatal, dose.

Officials said they had received 50 reports of adverse events associated with the use of intravenous colchicine, including 23 deaths.

"Today's action supports our ongoing efforts to end the marketing of unapproved drugs with serious health risks," said Dr. Janet Woodcock, the FDA's deputy commissioner for scientific and medical programs. "It is a priority that these products be removed from the market."

The FDA warned individuals and companies making the products to cease their activities within 30 days and stop shipping the product within 180 days or face regulatory action. Thereafter, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.

The FDA said its action announced Thursday does not affect colchicine products that are dispensed in tablet form and are frequently used to prevent gout attacks.

Copyright 2008 by United Press International

Explore further: Xtoro approved for swimmer's ear

add to favorites email to friend print save as pdf

Related Stories

N Korea-linked Sony hack may be costliest ever

21 minutes ago

A U.S. official says North Korea is linked to the unprecedented hack of Sony Pictures which exposed a trove of sensitive documents and escalated to threats of terrorism, driving the studio to cancel release ...

India launches biggest ever rocket into space

30 minutes ago

India successfully launched its biggest ever rocket on Thursday, including an unmanned capsule which could one day send astronauts into space, as the country ramps up its ambitious space programme.

Q&A: Drones might help show how tornados form

43 minutes ago

(AP)—Researchers say they've collected promising weather data by flying drones into big Western and Midwestern storms. Now they want to expand the project in hopes of learning how tornados form.

Recommended for you

Xtoro approved for swimmer's ear

12 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

12 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.